Infanrix hexa
Details for Infanrix hexa vaccine and its components.
Registered for use in infants and children aged ≥6 weeks.
DTPa-hepB-IPV-Hib — diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccine
The vaccine consists of both a 0.5 mL monodose pre-filled syringe and a vial containing a lyophilised pellet.
The pre-filled syringe contains:
- ≥30 IU diphtheria toxoid
- ≥40 IU tetanus toxoid
- 25 µg pertussis toxoid
- 25 µg filamentous haemagglutinin
- 8 µg pertactin
- 10 µg recombinant hepatitis B surface antigen (HBsAg)
- 40 D-antigen units inactivated poliovirus type 1 (Mahoney)
- 8 D-antigen units inactivated poliovirus type 2 (MEF-1)
- 32 D-antigen units inactivated poliovirus type 3 (Saukett)
Adsorbed onto aluminium hydroxide/phosphate.
Also contains traces of:
- formaldehyde
- polysorbate 80
- polysorbate 20
- polymyxin
- neomycin
The vial containing a lyophilised pellet contains:
- 10 µg purified Hib capsular polysaccharide conjugated to 20–40 µg tetanus toxoid
May contain yeast proteins.
For full details, refer to the product information and consumer medicine information sheets for Infanrix hexa vaccine available on the TGA website.
Page history
Definitions
- DTPa
- diphtheria-tetanus-acellular pertussis vaccine
- IPV
- inactivated poliomyelitis vaccine
- IU
- international units
- HBsAg
- hepatitis B surface antigen
Printed content may be out of date. For up to date information, always refer to the digital version: https://immunisationhandbook.health.gov.au/vaccines/infanrix-hexa.